Related Experiment Video
Updated: Apr 21, 2026
07:47
Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
Published on: December 25, 2021
3.8K
After clouds sun again shines on circulating tumor cells research
Guislaine Barriere1, Michel Rigaud1
1ASTRALAB, Clinical Laboratory, 7-11 Avenue de Lattre de Tassigny, 87000 Limoges, France.
Annals of Translational Medicine
|October 22, 2014
Summary
Researchers analyzed epithelial and mesenchymal circulating tumor cells (CTCs) using RNA in situ hybridization. The study highlights distinct CTC subpopulations resulting from epithelial-mesenchymal transition (EMT).
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Circulating tumor cells (CTCs) are crucial biomarkers in cancer metastasis.
- Understanding CTC heterogeneity is vital for effective cancer treatment.
- Epithelial-mesenchymal transition (EMT) is a key process in tumor cell dissemination.
Purpose of the Study:
- To comment on the characterization of epithelial and mesenchymal CTCs.
- To emphasize the significance of different CTC subpopulations in EMT.
Main Methods:
- RNA in situ hybridization was employed to characterize CTCs.
- Analysis focused on distinguishing between epithelial and mesenchymal CTC phenotypes.
Main Results:
- Yu et al. successfully characterized distinct epithelial and mesenchymal CTC populations.
- The findings underscore the presence of diverse CTC subpopulations.
Conclusions:
- EMT generates varied CTC subpopulations with distinct biological properties.
- Further research into CTC subpopulations is warranted for therapeutic advancements.
